TY - JOUR
T1 - Nonsyndromic craniosynostosis
T2 - novel coding variants
AU - Sewda, Anshuman
AU - White, Sierra R.
AU - Erazo, Monica
AU - Hao, Ke
AU - García-Fructuoso, Gemma
AU - Fernández-Rodriguez, Ivette
AU - Heuzé, Yann
AU - Richtsmeier, Joan T.
AU - Romitti, Paul A.
AU - Reva, Boris
AU - Jabs, Ethylin Wang
AU - Peter, Inga
N1 - Publisher Copyright:
© 2019, International Pediatric Research Foundation, Inc.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Background: Craniosynostosis (CS), the premature fusion of one or more neurocranial sutures, is associated with approximately 200 syndromes; however, about 65–85% of patients present with no additional major birth defects. Methods: We conducted targeted next-generation sequencing of 60 known syndromic and other candidate genes in patients with sagittal nonsyndromic CS (sNCS, n = 40) and coronal nonsyndromic CS (cNCS, n = 19). Results: We identified 18 previously published and 5 novel pathogenic variants, including three de novo variants. Novel variants included a paternally inherited c.2209C>G:p.(Leu737Val) variant in BBS9 of a patient with cNCS. Common variants in BBS9, a gene required for ciliogenesis during cranial suture development, have been associated with sNCS risk in a previous genome-wide association study. We also identified c.313G>T:p.(Glu105*) variant in EFNB1 and c.435G>C:p.(Lys145Asn) variant in TWIST1, both in patients with cNCS. Mutations in EFNB1 and TWIST1 have been linked to craniofrontonasal and Saethre–Chotzen syndrome, respectively; both present with coronal CS. Conclusions: We provide additional evidence that variants in genes implicated in syndromic CS play a role in isolated CS, supporting their inclusion in genetic panels for screening patients with NCS. We also identified a novel BBS9 variant that further shows the potential involvement of BBS9 in the pathogenesis of CS.
AB - Background: Craniosynostosis (CS), the premature fusion of one or more neurocranial sutures, is associated with approximately 200 syndromes; however, about 65–85% of patients present with no additional major birth defects. Methods: We conducted targeted next-generation sequencing of 60 known syndromic and other candidate genes in patients with sagittal nonsyndromic CS (sNCS, n = 40) and coronal nonsyndromic CS (cNCS, n = 19). Results: We identified 18 previously published and 5 novel pathogenic variants, including three de novo variants. Novel variants included a paternally inherited c.2209C>G:p.(Leu737Val) variant in BBS9 of a patient with cNCS. Common variants in BBS9, a gene required for ciliogenesis during cranial suture development, have been associated with sNCS risk in a previous genome-wide association study. We also identified c.313G>T:p.(Glu105*) variant in EFNB1 and c.435G>C:p.(Lys145Asn) variant in TWIST1, both in patients with cNCS. Mutations in EFNB1 and TWIST1 have been linked to craniofrontonasal and Saethre–Chotzen syndrome, respectively; both present with coronal CS. Conclusions: We provide additional evidence that variants in genes implicated in syndromic CS play a role in isolated CS, supporting their inclusion in genetic panels for screening patients with NCS. We also identified a novel BBS9 variant that further shows the potential involvement of BBS9 in the pathogenesis of CS.
UR - http://www.scopus.com/inward/record.url?scp=85060125535&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060125535&partnerID=8YFLogxK
U2 - 10.1038/s41390-019-0274-2
DO - 10.1038/s41390-019-0274-2
M3 - Article
C2 - 30651579
AN - SCOPUS:85060125535
SN - 0031-3998
VL - 85
SP - 463
EP - 468
JO - Pediatric Research
JF - Pediatric Research
IS - 4
ER -